chr15-29123573-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015307.2(ENTREP2):c.1386A>T(p.Gln462His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000143 in 1,399,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015307.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ENTREP2 | NM_015307.2 | c.1386A>T | p.Gln462His | missense_variant | 11/11 | ENST00000261275.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ENTREP2 | ENST00000261275.5 | c.1386A>T | p.Gln462His | missense_variant | 11/11 | 5 | NM_015307.2 | P1 | |
ENTREP2 | ENST00000560021.1 | n.1122A>T | non_coding_transcript_exon_variant | 8/8 | 1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000129 AC: 2AN: 155408Hom.: 0 AF XY: 0.0000243 AC XY: 2AN XY: 82432
GnomAD4 exome AF: 0.00000143 AC: 2AN: 1399416Hom.: 0 Cov.: 35 AF XY: 0.00000145 AC XY: 1AN XY: 690214
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2024 | The c.1386A>T (p.Q462H) alteration is located in exon 11 (coding exon 11) of the FAM189A1 gene. This alteration results from a A to T substitution at nucleotide position 1386, causing the glutamine (Q) at amino acid position 462 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at